Christopher Missling

Christopher Missling

President, Chief Executive Officer and DirectoratAnavex Life Sciences· In proxies 2021–2024

Pay in FY2024-29% from the year before · Anavex Life Sciences stock -13.3% the same year

Christopher Missling was paid $2.8M in FY2024 (Sep), down 29%. Anavex Life Sciences stock fell 13.3% that year.

Pay$100 in the stock at the end of FY20 → $125
Pay is from the Summary Compensation Table of each Anavex Life Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Anavex Life SciencesPublic company · 5 yr
    • President, Chief Executive Officer and Director2021 – Present · 5 yrStock in role -67%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?